Avanos Medical Inc (AVNS)

Interest coverage

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Earnings before interest and tax (EBIT) (ttm) US$ in thousands -385,800 50,700 40,100 27,500 13,900 22,000 32,900 44,900 60,200 58,300 52,000 33,600 12,000 -57,700 -64,300 -58,600 -44,900 -2,400 -19,300 -25,500
Interest expense (ttm) US$ in thousands 12,200 12,700 14,200 14,600 15,000 14,700 13,000 12,200 10,000 7,700 5,600 3,800 3,300 5,300 8,700 12,100 15,600 17,200 16,400 15,600
Interest coverage -31.62 3.99 2.82 1.88 0.93 1.50 2.53 3.68 6.02 7.57 9.29 8.84 3.64 -10.89 -7.39 -4.84 -2.88 -0.14 -1.18 -1.63

December 31, 2024 calculation

Interest coverage = EBIT (ttm) ÷ Interest expense (ttm)
= $-385,800K ÷ $12,200K
= -31.62

The interest coverage ratio measures a company's ability to meet its interest obligations with its operating income. A higher interest coverage ratio indicates that the company is more capable of servicing its debt.

For Avanos Medical Inc, the interest coverage ratio was negative for most of the periods from March 2020 to December 2021, indicating that the company's operating income was insufficient to cover its interest expenses during that time. This may suggest potential financial distress or liquidity concerns.

However, from March 2022 onwards, the interest coverage ratio turned positive and experienced a significant improvement, reaching 9.29 in June 2022. This indicates a positive shift in the company's ability to meet its interest obligations using its operating income.

In the latter half of 2022 and through 2024, the interest coverage ratio ranged between 0.93 and -31.62. The negative ratio in December 2024 could imply challenges in generating enough operating income to cover interest expenses.

Overall, Avanos Medical Inc's interest coverage ratio has shown fluctuations over the years, with periods of both weakness and improvement. It would be crucial to closely monitor this ratio to assess the company's financial health and its ability to manage debt effectively.